These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26995173)

  • 1. Commentary on Roberts et al. (2016): Bupropion and varenicline are efficacious and well-tolerated cessation medications for smokers with serious mental illness.
    Prochaska JJ
    Addiction; 2016 Apr; 111(4):613-4. PubMed ID: 26995173
    [No Abstract]   [Full Text] [Related]  

  • 2. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
    Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex difference in response to varenicline for smoking cessation.
    Gorelick DA
    Am J Psychiatry; 2015 Apr; 172(4):394-5. PubMed ID: 25827037
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.
    Roberts E; Eden Evins A; McNeill A; Robson D
    Addiction; 2016 Apr; 111(4):599-612. PubMed ID: 26594837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-nicotinic therapies for smoking cessation.
    Siu EC; Tyndale RF
    Annu Rev Pharmacol Toxicol; 2007; 47():541-64. PubMed ID: 17209799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counselors' knowledge of the adoption of tobacco cessation medications in substance abuse treatment programs.
    Rothrauff TC; Eby LT
    Am J Addict; 2011; 20(1):56-62. PubMed ID: 21175921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness and safety of varenicline for smoking cessation].
    Christalla P; Dewenter M; El-Armouche A
    Dtsch Med Wochenschr; 2012 May; 137(18):940-4. PubMed ID: 22492478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of varenicline to treat nicotine dependence among patients with cancer.
    Price S; Hitsman B; Veluz-Wilkins A; Blazekovic S; Brubaker TR; Leone F; Hole A; Wileyto EP; Langer C; Kalhan R; Patel J; Schnoll R
    Psychooncology; 2017 Oct; 26(10):1526-1534. PubMed ID: 27218657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy of varenicline and bupropion in smoking cessation: A meta-analysis of the randomized controlled trials.
    Zhong Z; Zhao S; Zhao Y; Xia S
    Compr Psychiatry; 2019 Nov; 95():152125. PubMed ID: 31669972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and meta-analysis of combination therapy for smoking cessation.
    Shah SD; Wilken LA; Winkler SR; Lin SJ
    J Am Pharm Assoc (2003); 2008; 48(5):659-65. PubMed ID: 18826906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline.
    Johnson TS
    J Am Acad Nurse Pract; 2010 Oct; 22(10):557-63. PubMed ID: 21040090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
    Etter JF; Schneider NG
    Nicotine Tob Res; 2013 Jan; 15(1):59-68. PubMed ID: 22529220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs for tobacco dependence.
    Treat Guidel Med Lett; 2008 Sep; 6(73):61-6. PubMed ID: 18719526
    [No Abstract]   [Full Text] [Related]  

  • 15. Smoking cessation.
    Rennard SI; Daughton DM
    Clin Chest Med; 2014 Mar; 35(1):165-76. PubMed ID: 24507844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating smoking cessation into HIV care.
    Drach L; Holbert T; Maher J; Fox V; Schubert S; Saddler LC
    AIDS Patient Care STDS; 2010 Mar; 24(3):139-40. PubMed ID: 20214480
    [No Abstract]   [Full Text] [Related]  

  • 17. Varenicline and related interventions on smoking cessation: A systematic review and network meta-analysis.
    Guo K; Zhou L; Shang X; Yang C; E F; Wang Y; Xu M; Wu Y; Li Y; Li M; Yang K; Li X
    Drug Alcohol Depend; 2022 Dec; 241():109672. PubMed ID: 36332593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current pharmacologic treatments for smoking cessation and new agents undergoing clinical trials.
    Nagano T; Katsurada M; Yasuda Y; Kobayashi K; Nishimura Y
    Ther Adv Respir Dis; 2019; 13():1753466619875925. PubMed ID: 31533544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy for smoking.
    Allan GM; Ivers N; Els C
    Can Fam Physician; 2011 Jan; 57(1):47. PubMed ID: 21252131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.